Current price is more than the intrinsic value

Intrinsic Value

Stock has not been able to generate better return on equity than bank FD

ROE vs FD rates

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

In Q4, KIMS Hospitals' revenue rose 4.9% on a year-on-year basis at Rs 380.5 crore vs Rs 362.7 crore. PAT was up 42.1% at Rs 83.3 crore. EBIDTA rose 15.9% at Rs 121.8 crore. Margins came in at 32% vs 29%. On a sequential basis, the revenue has been falling for three straight quarters at the group operating level. What may be the reason for this underperformance? What is your growth guidance for FY23? On average the occupancy levels stand at 60%. But in Q4FY22 occupancy levels dipped to 54%. Will the occupancy levels come back to over 60% in the coming quarter? Dr. B. Bhaskara Rao, Managing Director, KIMS Hospitals gives all the details on ET NOW.
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | https://bit.ly/SubscribeToETNow

To Stay Updated Download the Times Now App :-
Android Google Play :  https://goo.gl/zJhWjC
Apple App Store :  https://goo.gl/d7QBQZ

Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com

Subscribe Now To Our Network Channels:-
Times Now: https://bit.ly/SubscribeToTimesNow
Mirror Now: https://bit.ly/SubscribeToMirrorNow

Robust Q4 for KIMS Hospital | Dr B. Bhaskara Rao, Managing Director, KIMS Hospitals

Krishna Institute of Medical Sciences consolidated net profit rises 39.60% in the March 2022 quarter

Khambatta Securities is bullish on Krishna Institute of Medical Sciences has recommended buy rating on the stock with a target price of Rs 1776 in its research report dated March 14, 2022.

Buy Krishna Institute of Medical Sciencesg; target of Rs 1776: Khambatta Securities

A breathing lung transplantation was performed by doctors at the Krishna Institute of Medical Sciences (KIMS), Secunderabad, on Saturday. Doctors claimed that this was the first such procedure conduct

Breathing lung transplantation performed

Malabar Select Fund sold 4,01,224 shares of Krishna Institute of Medical Sciences (KIMS) at Rs 1319.04 per share. On the other hand, Nalanda India Equity Fund sold 20,21,814 shares of Kirloskar Oil Engineering at Rs 184.88 per share.

NSE-BSE bulk deals: Malabar Fund sells 4 lakh shares of KIMS

Krishna Institute of Medical Sciences consolidated net profit declines 2.11% in the September 2021 quarter

Krishna Institute of Medical Sciences saw a good growth in their margins in Q2FY22 as well as 59% occupancy. Dr. Bhaskara Rao Bollineni shares their business share from Covid and non-Covid patients.

#CNBCTV18 #BusinessNews #ShareMarketToday #Nifty #Sensex #DrBhaskaraRaoBollineni #KIMS

CNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise.

For latest news and updates visit our Website: https://bit.ly/2YbpXBM
Subscribe to our Channel: https://www.youtube.com/user/CNBCTV18
Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News

Dr. Bhaskara Rao Bollineni Of KIMS Shares Biz Share From COVID Vs Non-COVID Patients | Midcap Radar

In Q2, KIMS Hospital revenue came in at Rs 411.74 cr vs Rs 477.5 cr QoQ. EBITDA stood at Rs 134.18 cr vs Rs 147.9 cr QoQ. EBIDTA margin was 32.2% as compared to 31% in Q1. The net profit was reported at Rs 84.25 cr compared to Rs 92 cr QoQ. Speaking to ET NOW, Dr B. Bhaskar Rao, Managing Director, KIMS Hospitals says surgeries have come back to pre-COVID levels. He expects the coming quarters to be better than Q2. He believes that margins will be sustained as they have seen a surge in non-COVID cases. What are the upcoming trends in healthcare? Watch the full interview on The Market to find out all the details.

Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► https://goo.gl/SEjvK3

Subscribe Now To Our Network Channels :-
Times Now  : http://goo.gl/U9ibPb
The NewsHour Debate : http://goo.gl/LfNgFF

To Stay Updated Download the Times Now App :-
Android Google Play :  https://goo.gl/zJhWjC
Apple App Store :  https://goo.gl/d7QBQZ

Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com

Outpatient consultations rise; the company now debt-free | Dr B. Bhaskar Rao, KIMS Hospitals

Krishna Institute of Medical Sciences standalone net profit rises 0.45% in the September 2021 quarter

The acquisition deal is expected to be EPS accretive and provides an enhanced platform for KIMS.

KIMS Hospitals to acquire 51.07% stake in Sunshine Hospitals; Stock zooms 6%

The ratings are supported by the company’s healthy financial risk profile, and adequate liquidity.

CRISIL revises Krishna Institute of Medical Sciences’ outlook to ‘Positive’, reaffirms rating

Krishna Institute of Medical Sciences Ltd is engaged in the business of rendering medical and healthcare services. Its hospital network is spread across Andhra Pradesh,Telangana, Karnataka, Odisha, Tamil Nadu and Central India.

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

News Video

Robust Q4 for KIMS Hospital | Dr B. Bhaskara Rao, Managing Director, KIMS Hospitals

Krishna Institute of Medical Sciences consolidated net profit rises 39.60% in the March 2022 quarter

Buy Krishna Institute of Medical Sciencesg; target of Rs 1776: Khambatta Securities

Breathing lung transplantation performed

NSE-BSE bulk deals: Malabar Fund sells 4 lakh shares of KIMS

Krishna Institute of Medical Sciences consolidated net profit declines 2.11% in the September 2021 quarter

News Video

Dr. Bhaskara Rao Bollineni Of KIMS Shares Biz Share From COVID Vs Non-COVID Patients | Midcap Radar

News Video

Outpatient consultations rise; the company now debt-free | Dr B. Bhaskar Rao, KIMS Hospitals

Krishna Institute of Medical Sciences standalone net profit rises 0.45% in the September 2021 quarter

Krishna Institute of Medical Sciences Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

News Video

Robust Q4 for KIMS Hospital | Dr B. Bhaskara Rao, Managing Director, KIMS Hospitals

Krishna Institute of Medical Sciences consolidated net profit rises 39.60% in the March 2022 quarter

Buy Krishna Institute of Medical Sciencesg; target of Rs 1776: Khambatta Securities

Breathing lung transplantation performed

NSE-BSE bulk deals: Malabar Fund sells 4 lakh shares of KIMS

Krishna Institute of Medical Sciences consolidated net profit declines 2.11% in the September 2021 quarter

News Video

Dr. Bhaskara Rao Bollineni Of KIMS Shares Biz Share From COVID Vs Non-COVID Patients | Midcap Radar

News Video

Outpatient consultations rise; the company now debt-free | Dr B. Bhaskar Rao, KIMS Hospitals

Krishna Institute of Medical Sciences standalone net profit rises 0.45% in the September 2021 quarter

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock